Common stock and paid-in capital
Balance, beginning of period
78,520
80,552
83,111
Common stock issued
1,343
1,963
1,841
Common stock repurchased
(4,599)
(5,539)
(5,688)
Stock-based compensation expense
5,289
6,118
7,502
Balance, end of period
80,552
83,111
86,939
Balance, beginning of period
24,150
34,566
57,055
Net income
44,281
61,271
72,738
Common stock cash dividends
(15,483)
(16,871)
(18,552)
Common stock repurchased
(18,382)
(21,879)
(26,960)
Cumulative effect of accounting changes
0
(32)
0
Balance, end of period
34,566
57,055
84,281
Accumulated other comprehensive income (loss)
Balance, beginning of period
(340)
3,186
1,822
Other comprehensive income (loss)
3,526
(1,374)
(6,500)
Cumulative effect of accounting changes
0
10
0
Balance, end of period
3,186
1,822
(4,678)
Total stockholders’ equity
118,304
141,988
166,542
Cash dividends declared per common share
2
2
2